[Pulmonary hypertension in chronic obstructive pulmonary disease can not be ignored].
Qiu-yue
QY
Wang
Ming-na
MN
Zhang
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D004452:Echocardiography / Q000379:methods; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D008168:Lung / Q000000981:diagnostic imaging / Q000473:pathology / Q000503:physiopathology; D015999:Multivariate Analysis; D011379:Prognosis; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000503:physiopathology; D011859:Radiography; D012129:Respiratory Function Tests; D012307:Risk Factors; D012720:Severity of Illness Index; D014665:Vasodilator Agents / Q000627:therapeutic use*; D016278:Ventricular Function, Right
D000959:Antihypertensive Agents; D014665:Vasodilator Agents